Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Bilcare Limited (BI.BO)

Compare
87.31
-4.02
(-4.40%)
At close: April 17 at 3:44:20 PM GMT+5:30
Loading Chart for BI.BO
  • Previous Close 91.33
  • Open 89.51
  • Bid 87.04 x --
  • Ask 87.62 x --
  • Day's Range 87.01 - 91.89
  • 52 Week Range 52.35 - 97.99
  • Volume 22,787
  • Avg. Volume 43,122
  • Market Cap (intraday) 2.056B
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) --
  • EPS (TTM) -17.20
  • Earnings Date May 26, 2025 - May 30, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 20, 2012
  • 1y Target Est --

Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for packaging of solid dosage pharmaceutical products. It also offers CR, blister, and lidding foils; blister films and laminates. In addition, the company engages in the provision of the clinical supplies, and research and development services. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.

www.bilcare.com

73

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BI.BO

View More

Performance Overview: BI.BO

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BI.BO
33.16%
S&P BSE SENSEX (^BSESN)
0.53%

1-Year Return

BI.BO
22.99%
S&P BSE SENSEX (^BSESN)
7.69%

3-Year Return

BI.BO
22.99%
S&P BSE SENSEX (^BSESN)
34.65%

5-Year Return

BI.BO
22.99%
S&P BSE SENSEX (^BSESN)
148.67%

Compare To: BI.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BI.BO

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    2.06B

  • Enterprise Value

    8.93B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.26

  • Price/Book (mrq)

    0.43

  • Enterprise Value/Revenue

    1.14

  • Enterprise Value/EBITDA

    32.93

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.10%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    7.94B

  • Net Income Avi to Common (ttm)

    -404.92M

  • Diluted EPS (ttm)

    -17.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    409.8M

  • Total Debt/Equity (mrq)

    122.77%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BI.BO

View More

Company Insights: BI.BO

Research Reports: BI.BO

View More

People Also Watch